Editorial for "Potential Anti-Human Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer"

被引：0
|
作者：
Geitung, Jonn Terje [1 ,2 ]
机构：
[1] Univ Oslo, Oslo, Norway
[2] Akershus Univ Hosp, Oslo, Norway
来源：
JOURNAL OF MAGNETIC RESONANCE IMAGING | 2023年 / 58卷 / 05期
关键词：
D O I：
10.1002/jmri.28626
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1615 / 1616
页数：2
相关论文
共 50 条
  • [1] Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer
    Bian, Xiaoqian
    Du, Siyao
    Yue, Zhibin
    Gao, Si
    Zhao, Ruimeng
    Huang, Guoliang
    Guo, Liangcun
    Peng, Can
    Zhang, Lina
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 58 (05) : 1603 - 1614
  • [2] New approaches for human epidermal growth factor receptor 2-low and human epidermal growth factor receptor 2-overexpressing metastatic breast cancer
    Britten, Karissa
    McAndrew, Nicholas
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2024, 36 (01) : 34 - 39
  • [3] Anti-human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer
    Leonard, DS
    Hill, ADK
    Kelly, L
    Dijkstra, B
    McDermott, E
    O'Higgins, NJ
    BRITISH JOURNAL OF SURGERY, 2002, 89 (03) : 262 - 271
  • [4] The Emergence of the Potential Therapeutic Targets: Ultrasound- Based Radiomics in the Prediction of Human Epidermal Growth Factor Receptor 2-Low Breast Cancer
    Du, Yu
    Li, Fang
    Zhang, Manqi
    Pan, Jiazhen
    Wu, Tingting
    Zheng, Yi
    Chen, Jing
    Yao, Minghua
    Kuang, Yi
    Wu, Rong
    Diao, Xuehong
    ACADEMIC RADIOLOGY, 2024, 31 (07) : 2674 - 2683
  • [5] Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer
    Henry, Kelly E.
    Ulaner, Gary A.
    Lewis, Jason S.
    PET CLINICS, 2018, 13 (03) : 423 - +
  • [6] Human epidermal growth factor receptor 2 status in breast cancer: A comparison between borderline positive human epidermal growth factor receptor 2 and strongly positive human epidermal growth factor receptor 2 tumors
    Huszno, Joanna
    Nowara, Elibieta
    CLINICAL CANCER INVESTIGATION JOURNAL, 2015, 4 (03): : 307 - 311
  • [7] Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer
    Mukohara, Toru
    CANCER SCIENCE, 2011, 102 (01) : 1 - 8
  • [8] Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: a systematic review
    Zhang, Xiao
    Zhang, Xin-Ji
    Zhang, Tian-Yi
    Yu, Fei-Fei
    Wei, Xin
    Li, Ye-Sheng
    He, Jia
    BMC CANCER, 2014, 14
  • [9] Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: a systematic review
    Xiao Zhang
    Xin-Ji Zhang
    Tian-Yi Zhang
    Fei-Fei Yu
    Xin Wei
    Ye-Sheng Li
    Jia He
    BMC Cancer, 14
  • [10] Human Epidermal Growth Factor Receptor 2 "Low" in Breast Cancer in 2023
    Laffer, Shabnam
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (09) : 989 - 990
12345